These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9756413)

  • 41. Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells.
    Cardoso AA; Seamon MJ; Afonso HM; Ghia P; Boussiotis VA; Freeman GJ; Gribben JG; Sallan SE; Nadler LM
    Blood; 1997 Jul; 90(2):549-61. PubMed ID: 9226154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Importance of TNF production for the curative effectiveness of low dose melphalan therapy for mice bearing a large MOPC-315 tumor.
    Gorelik L; Rubin M; Prokhorova A; Mokyr MB
    J Immunol; 1995 Apr; 154(8):3941-51. PubMed ID: 7706732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity.
    Van Gool SW; de Boer M; Ceuppens JL
    J Immunol; 1993 Apr; 150(8 Pt 1):3254-63. PubMed ID: 7682237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation.
    Thebeau LG; Morrison LA
    J Virol; 2003 Feb; 77(4):2426-35. PubMed ID: 12551980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.
    Bai XF; Liu J; May KF; Guo Y; Zheng P; Liu Y
    Blood; 2002 Apr; 99(8):2880-9. PubMed ID: 11929778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.
    Yang Y; Wilson JM
    Science; 1996 Sep; 273(5283):1862-4. PubMed ID: 8791591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T lymphocyte and monocyte interaction by CD40/CD40 ligand facilitates a lymphoproliferative response and killing of Cryptococcus neoformans in vitro.
    Vecchiarelli A; Retini C; Pietrella D; Monari C; Kozel TR
    Eur J Immunol; 2000 May; 30(5):1385-93. PubMed ID: 10820385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation.
    Zhan Y; Corbett AJ; Brady JL; Sutherland RM; Lew AM
    J Immunol; 2000 Oct; 165(7):3612-9. PubMed ID: 11034363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
    Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
    J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells.
    Hu HM; Winter H; Ma J; Croft M; Urba WJ; Fox BA
    J Immunol; 2002 Nov; 169(9):4897-904. PubMed ID: 12391201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
    Hancock WW; Sayegh MH; Zheng XG; Peach R; Linsley PS; Turka LA
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13967-72. PubMed ID: 8943044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression and functional role of co-stimulatory molecules in CD40+IL-4-stimulated B cells from atopic and non-atopic donors.
    Oberwalleney G; Henz BM; Worm M
    Acta Derm Venereol; 2000; 80(4):287-91. PubMed ID: 11028864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.
    Kennedy MK; Picha KS; Fanslow WC; Grabstein KH; Alderson MR; Clifford KN; Chin WA; Mohler KM
    Eur J Immunol; 1996 Feb; 26(2):370-8. PubMed ID: 8617306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.
    Yellin MJ; Brett J; Baum D; Matsushima A; Szabolcs M; Stern D; Chess L
    J Exp Med; 1995 Dec; 182(6):1857-64. PubMed ID: 7500031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.
    Borrow P; Tishon A; Lee S; Xu J; Grewal IS; Oldstone MB; Flavell RA
    J Exp Med; 1996 May; 183(5):2129-42. PubMed ID: 8642323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
    Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of costimulation to enhance tumor immunity.
    Vesosky B; Hurwitz AA
    Cancer Immunol Immunother; 2003 Nov; 52(11):663-9. PubMed ID: 12920481
    [No Abstract]   [Full Text] [Related]  

  • 59. Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma.
    Cook-Mills JM; Mokyr MB; Cohen RL; Perlman RL; Chambers DA
    Cancer Immunol Immunother; 1995 Feb; 40(2):79-87. PubMed ID: 7882386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon gamma in the therapeutic outcome.
    Gorelik L; Mokyr MB
    Cancer Immunol Immunother; 1995 Dec; 41(6):363-74. PubMed ID: 8635194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.